Pediatric T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma therapy

Haematologica Meeting Reports

Volumn 3, Issue 1, 2009, Pages 111-114

  Pession, A ^a   Masetti, R ^a   Rondelli, R ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CHILDHOOD DISEASE; CONFERENCE PAPER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; LYMPHATIC LEUKEMIA; PRE T LYMPHOCYTE; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL; T CELL LYMPHOMA; T LYMPHOCYTE;

EID: 69749107112     PISSN: 19707339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166-178 Review.
2. Tucci F, Aricò M. Treatment of pediatric acute lymphoblastic leukemia. Haematologica 2008;93:1124-1128
3. Flohr T, Schrauder A, Cazzaniga G, Panzer-Grümayer R, van der Velden V, Fischer S, et al. International BFM Study Group (I-BFM-SG). Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia. 2008;22:771-782 Epub 2008 Jan 31.
4. Willemse MJ, Seriu T, Hettinger K, d'Aniello E, Hop WC, Panzer-Grümayer ER, et al. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. Blood 2002;99:4386-4393
5. Pui CH. Acute lymphoblastic leukemia: introduction. Semin Hematol 2009;46:1-2.
6. Aricò M, Valsecchi MG, Rizzari C, Barisone E, Biondi A, Casale F,et al.. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. J Clin Oncol 2008;26:283-289
7. Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 2009. [Epub ahead of print]
8. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371:1030-1043 Review.
9. Kindler T, Cornejo MG, Scholl C, Liu J, Leeman DS, Haydu JE, et al. K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors. Blood. 2008;112:3373-3382 Epub 2008 Jul 28.
10. Pear WS, Aster JC. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol 2004;11:426-433 Review.
11. Chiaretti S, Foà R. T-cell acute lymphoblastic leucemia. Haematologica 2009;94:160-162
12. Conter V, Arico M, Valsecchi MG, et al. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukaemia studies, 1982-1995. Leukemia 2000;14:2196-2204
13. Larson RA.Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine. Semin Oncol 2007;34:S13-20. Review.
14. Reiter A, Schrappe M, Parwaresch R et al. Non-Hodgkin's lymphomas of childhood and adolescence:results of a treatment stratified for biologic subtypes and stage-a report of the Berlin-Frankfurt-MunsterGroup. J Clin Oncol 1995;13:359-372
15. Wollner N, Burchenal JH, Lieberman PH et al. Non-Hodgkin's lymphoma in children. Acomparative study of two modalities of therapy. Cancer 1976;37:123-134
16. Muller-Weihrich S, Henze G, Jobke A et al. [BFM study 1975/81 for treatment of non-Hodgkin lymphoma ofhigh malignancy in children and adolescents]. Klin Padiatr 1982;194:219-225
17. Anderson JR, Wilson JF, Jenkin DT et al. Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med 1983;308:559-565
18. Eden OB, Hann I, Imeson J et al. Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503. Br J Haematol 1992;82:310-316
19. Tubergen DG, Krailo MD, Meadows AT et al. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. J Clin Oncol 1995;13:1368-1376
20. Reiter A, Schrappe M, Parwaresch R et al. Non- Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Munster Group. J Clin Oncol 1995;13:359-372